GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (SZSE:300357) » Definitions » 3-Year Revenue Growth Rate

Zhejiang Wolwo Bio-Pharmaceutical Co (SZSE:300357) 3-Year Revenue Growth Rate : 10.10% (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Zhejiang Wolwo Bio-Pharmaceutical Co 3-Year Revenue Growth Rate?

Zhejiang Wolwo Bio-Pharmaceutical Co's Revenue per Share for the three months ended in Mar. 2024 was ¥0.41.

During the past 12 months, Zhejiang Wolwo Bio-Pharmaceutical Co's average Revenue per Share Growth Rate was -0.10% per year. During the past 3 years, the average Revenue per Share Growth Rate was 10.10% per year. During the past 5 years, the average Revenue per Share Growth Rate was 11.80% per year. During the past 10 years, the average Revenue per Share Growth Rate was 17.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Zhejiang Wolwo Bio-Pharmaceutical Co was 66.40% per year. The lowest was 10.10% per year. And the median was 17.30% per year.


Competitive Comparison of Zhejiang Wolwo Bio-Pharmaceutical Co's 3-Year Revenue Growth Rate

For the Drug Manufacturers - General subindustry, Zhejiang Wolwo Bio-Pharmaceutical Co's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Wolwo Bio-Pharmaceutical Co's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Wolwo Bio-Pharmaceutical Co's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Zhejiang Wolwo Bio-Pharmaceutical Co's 3-Year Revenue Growth Rate falls into.



Zhejiang Wolwo Bio-Pharmaceutical Co 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Zhejiang Wolwo Bio-Pharmaceutical Co  (SZSE:300357) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Zhejiang Wolwo Bio-Pharmaceutical Co 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Zhejiang Wolwo Bio-Pharmaceutical Co's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Wolwo Bio-Pharmaceutical Co (SZSE:300357) Business Description

Traded in Other Exchanges
N/A
Address
No. 636 Zhiyuan North Road, Wukang Town, Deqing County, Zhejiang Province, Huzhou, CHN, 313299
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd is a Chinese bio-pharmaceutical company. It is engaged in the research development, production and sales of allergic diseases diagnosis and treatment products. The product portfolio of the company covers dust mites drops, dust mites skin prick diagnosis kit, silk, and others.

Zhejiang Wolwo Bio-Pharmaceutical Co (SZSE:300357) Headlines

No Headlines